TABLE 5.
Applications of SHEDs in bone tissue repair.
| Cell type | Material/scaffold | Experimental model | Experimental subject | Results and conclusions | References |
|---|---|---|---|---|---|
| SHEDs | SHED-CM | Skull defect | mouse | It can significantly increase the volume of new bone, the proportion of mature bone, and vascular density, and is rich in osteogenic and angiogenic factors | Hiraki et al. (2020) |
| SHEDs | PGH | Skull defect | mouse | The expression of osteogenic genes such as ALP, RUNX2, and OCN was significantly upregulated. The amount of new bone formed within 8 weeks was high, and mature bone and blood vessels grew in synchrony without any inflammatory response | Sattary et al. (2022) |
| SHEDs | PLGA-10% bioactive glass composite scaffold | Alveolar bone cleft | rat | Within 14 days, the activity of ALP and the expression of RUNX2, OCN and Col1 were significantly increased, mature bone matrix could be formed, and osteocalcin was positive | Kunwong et al. (2021) |
SHEDs, Stem cells populations from human exfoliated deciduous teeth; CM, conditioned medium; PGH, Polycaprolactone/gelatin/hydroxyapatite Nanoparticles; PLGA, Poly (lactic-co-glycolic acid); ALP, alkaline phosphatase; OCN, osteocalcin.